FDA-Inspected Site

E2E PHARMA LLC

1 FDA inspection is on record for E2E PHARMA LLC in Phoenix, United States.

483· Form 483 issued

Phoenix, United States · Last updated July 12, 2026

Overview

  • 1 FDA inspection is on record.
  • 1 inspection produced a Form 483.
  • The most recent recorded inspection date is 2026-06-10.

At a glance

Inspections

1

Form 483s

1

EIRs

0

Last outcome

Form 483

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
3 Jun 2026 – 10 Jun 2026Foods & Cosmetics483View 483 →

Observations on record

Form 483 observations cited at this site, most recent first.

10 Jun 2026
21 CFR 111.105(a)

Quality control - processes, specifications, written procedures

Cited by Alan Escalona

10 Jun 2026
21 CFR 111.205(a)

Master manufacturing record - prepared

Cited by Alan Escalona

10 Jun 2026
21 CFR 111.255(b)

Batch record - complete

Cited by Alan Escalona

10 Jun 2026
21 CFR 111.27(b)

Instruments - calibration

Cited by Alan Escalona

10 Jun 2026
21 CFR 111.70(b)

Specifications - components

Cited by Alan Escalona

Investigators

FDA investigators tied to this site in the record.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 111.105(a)Cited across public-safe Form 483 observations1x
21 CFR 111.205(a)Cited across public-safe Form 483 observations1x
21 CFR 111.255(b)Cited across public-safe Form 483 observations1x
21 CFR 111.27(b)Cited across public-safe Form 483 observations1x
21 CFR 111.70(b)Cited across public-safe Form 483 observations1x
21 CFR 111.70(e)Cited across public-safe Form 483 observations1x
21 CFR 111.75(a)(2)(ii)(A)Cited across public-safe Form 483 observations1x
21 CFR 111.75(f)(2)Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind E2E PHARMA LLC's 1 Form 483

Recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat